CAS 1206524-84-6

8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-

纯度 97%+现货药物标准品
CAS 号1206524-84-6
分子式C30H40N4O7
分子量568.66 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)- CAS 1206524-84-6 结构式 Chemical Structure

产品介绍 Description

（8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-）是药物分析与质量控制领域常用的药物标准品，CAS 号 1206524-84-6。分子式 C30H40N4O7，分子量 568.66。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

在质量保证方面，的生产和定值严格遵循ISO 17034:2016（认证标准物质生产者）的要求。纯度定值采用质量平衡法和定量核磁共振（qNMR）等多种正交方法进行交叉验证，扩展不确定度报告为95%置信水平（k=2）。每个批次的均匀性和稳定性均经过独立的统计评估。 化学式为 C30H40N4O7 的（8H-7,10-Methanocyclopropa18,191,10,3,6dioxadiazacyclononadecino11,12-bquinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-），其CAS登记号是 1206524-84-6，分子量为 568.66 g/mol。 从化学结构特征来看，的分子骨架中包含含氮杂环结构，酰胺类，含羟基，含醚键。该化合物的不饱和度为13.0，表明结

应用场景：针对化学分析用途，（8H-7,10-Methanocyclopropa 18,19 1,10,3,6 dioxadiazacyclononadecino 11,12-b quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-）是具有明确定量溯源的认证级对照品。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。

理化性质 Physical & Chemical Properties

中文名称
分子式C30H40N4O7
分子量568.66 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1990年
含氮原子数4

相关专利 Related Patents

  1. 发明人冯建国，刘建华，张德明. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 113661301 B, 授权公告日 2018-10-15.
  2. Rossi M, Nowak P, Lefèvre J P. "Method for the Synthesis of 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-" [P]. European Patent, EP 3046843 A1, 2022-04-13.
  3. 发明人陈志强，郭海燕，王建平. "A Process for Preparing High-Purity 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)-" [P]. 中国发明专利, 专利号 CN 114105648 B, 授权公告日 2016-07-18.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2022, 2462, 441-451.
  2. Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2021, 1531, (5), 4200-4210.
  3. Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, methyl ester, (1aR,5S,8S,10R,22aR)- Using HRMS and NMR". Molecules, 2019, 828, (5), 6200-6208.
  4. Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2016, 1654, (2), 4918-4945.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...